Nachrichten zur Bristol-Myers Squibb Co. Aktie

Final Trades: PayPal, Merck, Bristol Myers & more

The "Halftime Report" traders give their top picks to watch for the second half....…

Global Peripheral Neuropathy Market Report 2022: Featuring Abbott, Eli Lilly and Company, GlaxoSmithKline, Bristol Myers Squibb & More

DUBLIN, Nov. 9, 2022 /PRNewswire/ -- The "Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key…

Die neue BioNTech - Immuntherapie vor dem Durchbruch

In den letzten Jahren haben diverse Wirkstoffe im Bereich Krebsimmuntherapie – wie etwa von Merck Sharp & Dohme und Bristol-Myers…

US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead

read more...…

Bristol Myers bid for $1.2B Gilead patent award rejected by Supreme Court

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead

... 7 (Reuters) - The U.S. Supreme Court on Monday rebuffed a bid......…

U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead

...By Blake Brittain WASHINGTON (Reuters) -The U.S. Supreme Court......…

The Zacks Analyst Blog Highlights Berkshire Bristol-Myers Squibb, Verizon Communications, Canadian National Railway, Airbnb and First Republic Bank

Berkshire Bristol-Myers Squibb, Verizon Communications, Canadian National Railway, Airbnb and First Republic Bank are included in this Analyst Blog....…

Top Analyst Reports for Bristol-Myers, Verizon & Canadian National Railway

Todays Research Daily features new research reports on 16 major stocks, including Berkshire Bristol-Myers Squibb Company (BMY), Verizon Communications Inc.…

6 Stocks With Healthy Dividends and Solid Returns

AbbVie, Gilead Sciences, Cardinal Health, Merck, Bristol Myers, and Amgen are large-cap healthcare companies that have the capacity to grow…

Bristol Myers says Merck-partnered blood cancer therapy met main goal in Phase 3 trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

If You Invested $10,000 in Bristol Myers Squibb 5 Years Ago, This Is How Much You Would Have Today

The stock has been beating the market this year -- and that says a lot....…

Is Bristol Myers Squibb Stock a Buy With Its New-Product Sales Soaring?

The biopharma company has a lot riding on its new drugs....…

Health Care Up After Bristol Myers Earnings -- Health Care Roundup

Health Care Up After Bristol Myers Earnings -- Health Care Roundup...…

Bristol Myers Squibb (BMY) Q3 2022 Earnings Call Transcript

BMY earnings call for the period ending September 30, 2022....…

Bristol-Myers (BMY) Q3 Earnings Beat, Sales Decline Y/Y

Bristol-Myers (BMY) third-quarter 2022 earnings beat estimates while sales miss the same due to a decline in sales of Revlimid....…

Form 10-Q BRISTOL MYERS SQUIBB CO For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb CEO: We are on track to continue delivering growth

Bristol Myers Squibb CEO Dr. Giovanni Caforio joins CNBC's 'Squawk on the Street' to discuss the company's third-quarter earnings report....…

Bristol Myers Stock Higher As Opdivo, Eliquis Sales Power Q3 Earnings Beat

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibbs stock is up, says Revlimid sales are declining

Shares of Bristol Myers Squibb were up 1.2% in premarket trading on Wednesday, the day after the company shared…

Form 8-K BRISTOL MYERS SQUIBB CO For: Oct 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers MS drug Zeposia recipients mounted serologic response to COVID vaccines in trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Sales Fall on Strong Dollar. But Earnings Beat Expectations.

Sales of the company's blockbuster cancer drug Revlimid, which has faced increased competition this year, tumbled 28% in the quarter....…

Bristol Myers Squibb Non-GAAP EPS of $1.99 beats by $0.16, revenue of $11.22B beats by $40M, re-affirms FY22 outlook

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb (BMY) Tops Q3 Earnings and Revenue Estimates

Bristol Myers (BMY) delivered earnings and revenue surprises of 8.74% and 1.63%, respectively, for the quarter ended September 2022. Do…

Bristol Myers Q3 sales fall on Revlimid, forex pressure

...Oct 25 (Reuters) - Drugmaker Bristol Myers Squibb said on Tuesday its......…

Bristol Myers Squibb Q3 2022 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B

Jenny Hsieh joins Actinium as Chief Strategy Officer from Gilead Sciences, following its acquisition of Immunomedics Sunitha Lakshminarayanan, Senior Vice…

Earnings Previews: Boeing, Bristol-Myers Squibb, Kraft Heinz

Here is a look at what to expect when these three companies report quarterly results before markets open on Wednesday....…

Will Eliquis, Opdivo Fuel Bristol-Myers (BMY) Q3 Earnings?

Investors are likely to focus on the demand for Eliquis and Opdivo along with an incremental contribution from newer drugs…

Thinking about trading options or stock in Moderna, Bristol-Myers Squibb, Northrop Grumman, BioNTech, or Tesla?

NEW YORK, Oct. 21, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, BMY, NOC, BNTX, and TSLA. Click…

Bristol Myers: FDA to Review Camzyos to Reduce Septal-Reduction Therapy Need

Bristol Myers: FDA to Review Camzyos to Reduce Septal-Reduction Therapy Need...…

Bristol Myers Squibb (BMY) Stock Moves -0.21%: What You Should Know

Bristol Myers Squibb (BMY) closed at $70.62 in the latest trading session, marking a -0.21% move from the prior day....…

Why Bristol Myers (BMY) is Poised to Beat Earnings Estimates Again

Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb

Within the last quarter, Bristol-Myers Squibb (NYSE:BMY) has observed the following analyst ratings: Latest Ratings for BMY …

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring…

6 Analysts Have This to Say About Bristol-Myers Squibb

Within the last quarter, Bristol-Myers Squibb (NYSE:BMY) has observed the following analyst ratings: Latest Ratings for BMY …

Bristol-Myers cut to Neutral at Guggenheim citing overly bullish consensus

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know

Bristol Myers Squibb (BMY) closed at $70.24 in the latest trading session, marking a -1.69% move from the prior day....…

There are early signs that the bear market is going into hibernation

Also, new options-trade recommendations for Harmonic and Bristol-Myers Squibb....…

XETR : DIVIDEND/INTEREST INFORMATION - 06.10.2022 - US1101221083

Das Instrument BRM US1101221083 BRISTOL-MYERS SQUIBBDL-10 EQUITY wird ex Dividende/Zinsen gehandelt am 06.10.2022 The instrument BRM US1101221083 BRISTOL-MYERS SQUIBBDL-10 EQUITY has…

LabCentral Ignite Awards Four Golden Tickets to Support Entrepreneurial Diversity in Biotech

Underrepresented biotech founders developing novel health solutions will gain access to LabCentrals lab space, resources and community CAMBRIDGE, Mass., Oct.…

Exelixis Expands Agreement With Bristol Myers For STELLAR-002 Trial

NEW YORK CITY (dpa-AFX) - Exelixis, Inc. (EXEL) announced the expansion of clinical trial collaboration and supply agreement with Bristol-Myers…

Autolus stock rises on Bristol Myers contract for use of safety switch with cell therapies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Autolus Therapeutics Shares Jump After Cancer-Collaboration Agreement with Bristol Myers

Autolus Therapeutics Shares Jump After Cancer-Collaboration Agreement with Bristol Myers...…

Should Investors Buy Bristol Myers Squibb Stock?

BMYs YTD performance indicates the stock has been a viable hedge against inflation because people can ill afford to cut…

Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?

Bristol Myers (BMY) expects recent drug approvals to generate an incremental stream of revenues and combat competition for its key…

US-Pharmakonzern Bristol-Myers hält an Ergebniszielen fest

New York (Reuters) - Der US-Pharmakonzern Bristol Myers Squibb hat im ersten Quartal besser als erwartet abgeschnitten und seine Ergebnisprognose…